Anixa Biosciences Granted First Korean Patent for its Breast Cancer Vaccine, Extending Global Protection Through 2040
Go back to Anixa Biosciences Granted First Korean Patent for its Breast Cancer Vaccine, Extending Global Protection Through 2040| (NASDAQ: ANIX) | Delayed: 2.70 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.70 | 52 Week High | $ | |||
| Open | $2.70 | 52 Week Low | $ | |||
| Day High | $2.70 | P/E | N/A | |||
| Day Low | $2.70 | EPS | $ | |||
| Volume | 2 | |||||

